"...as placebo group in trial were screened for 2 weeks and those showing wound reduction were discluded."
I don't understand this. Are you saying that in that benchmark trial those showing wound reduction were discluded? If that's the case the placebo group in our trial will do better as those showing early wound reduction are still there.
- Forums
- ASX - By Stock
- DLM
- Ann: Investor Presentation
Ann: Investor Presentation, page-9
-
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DLM (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DLM (ASX) Chart |
Day chart unavailable
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online